91 results
10QSB
2004 Q1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
13 May 04
Quarterly report (small business)
12:00am
the above $13,750 planned expense, but
we are confident that total revenues will be sufficient to offset the 15% cash
expense per month.
Results … of Operations
Sales of Cyclodextrins and related manufactured complexes are historically
highly volatile. In efforts to offset this volatility, we
10QSB
1997 Q3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 97
Quarterly report (small business)
12:00am
deferred for the
nine months ended September 30, 1996, was $127,371. These deferred
professional costs were to be offset against the net proceeds … volatile. Sales are primarily to large pharmaceutical and food
companies for research and development purposes. In efforts to offset
10QSB
2002 Q1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
16 May 02
Quarterly report (small business)
12:00am
and related manufactured complexes are historically highly
volatile. In efforts to offset this volatility, the Company continues to expand
its revenue
PRE 14C
kh58uan37h4yqka8
8 Jun 04
Preliminary information
12:00am
ARS
d63pm
9 Jan 97
Annual report to shareholders
12:00am